Literature DB >> 17095078

Randomized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia.

Mischel G Neill1, Peter J Gilling, Katie M Kennett, Christopher M Frampton, Andre M Westenberg, Mark R Fraundorfer, Liam C Wilson.   

Abstract

OBJECTIVES: To compare the alternative energy sources of the holmium:yttrium-aluminum-garnet laser and bipolar plasmakinetic energy for endoscopic enucleation.
METHODS: A prospective, randomized controlled trial was undertaken, with 20 patients assigned to each group. The preoperative and postoperative measures included transrectal ultrasound-assessed prostate volume, postvoid residual urine volume, and urodynamic evaluation findings. The intraoperative measures included procedure length, energy use, and specimen weight. All adverse events were recorded at each postoperative visit in a 1, 3, 6, and 12-month protocol.
RESULTS: No differences were found in the preoperative characteristics between the two groups. The significant differences favoring holmium laser enucleation of the prostate compared with plasmakinetic enucleation of the prostate were seen in the operative time (43.6 versus 60.5 minutes), recovery room time (47.1 versus 65.6 minutes), and bladder irrigation requirement (5% versus 35%). The outcomes after holmium laser enucleation of the prostate and plasmakinetic enucleation of the prostate were in all other respects similar by the postoperative outcome measures assessed.
CONCLUSIONS: Plasmakinetic enucleation of the prostate is a safe and technically feasible procedure for the enucleation of prostatic adenomata. Plasmakinetic enucleation of the prostate is limited by the longer operative and recovery room times, as well as a more pronounced postoperative irrigation requirement because of reduced visibility and a greater propensity for bleeding. The transfusion rates and catheterization and hospitalization times were similar. The optimal energy source for enucleation should still be considered the holmium laser, but bipolar energy can be considered by users already experienced with holmium laser enucleation of the prostate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095078     DOI: 10.1016/j.urology.2006.06.021

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  35 in total

Review 1.  Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Youcheng Lin; Xun Wu; Abai Xu; Rui Ren; Xueqiong Zhou; Yong Wen; Yong Zou; Mancheng Gong; Chunxiao Liu; Zexuan Su; Thomas R W Herrmann
Journal:  World J Urol       Date:  2015-12-23       Impact factor: 4.226

2.  A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up.

Authors:  Gang Wu; Zhe Hong; Chao Li; Cuidong Bian; Shengsong Huang; Denglong Wu
Journal:  Lasers Med Sci       Date:  2016-01-28       Impact factor: 3.161

3.  Endoscopic enucleation for prostate larger than 60 mL: comparison between holmium laser enucleation and plasmakinetic enucleation.

Authors:  P- M Patard; M Roumiguie; S Sanson; J- B Beauval; E Huyghe; M Soulié; B Malavaud; X Gamé; P Rischmann
Journal:  World J Urol       Date:  2020-07-27       Impact factor: 4.226

4.  Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial.

Authors:  B Becker; T R W Herrmann; A J Gross; C Netsch
Journal:  World J Urol       Date:  2018-05-05       Impact factor: 4.226

5.  [Transurethral enucleation of the prostate with the holmium: YAG laser system: how much power is necessary?].

Authors:  J Rassweiler; M Roder; M Schulze; R Muschter
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

6.  Holmium laser enucleation of the prostate: a paradigm shift in benign prostatic hyperplasia surgery.

Authors:  Tevita F Aho
Journal:  Ther Adv Urol       Date:  2013-10

7.  A prospective study comparing bipolar endoscopic enucleation of prostate with bipolar transurethral resection in saline for management of symptomatic benign prostate enlargement larger than 70 g in a matched cohort.

Authors:  Chi Fai Kan; Hok Leung Tsu; Yi Chiu; Hoi Chu To; Bonnie Sze; Steve Wai Hee Chan
Journal:  Int Urol Nephrol       Date:  2013-09-08       Impact factor: 2.370

8.  [Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].

Authors:  R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

9.  Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies.

Authors:  Chaohui Gu; Naichun Zhou; Pratik Gurung; Yiping Kou; Yang Luo; Yidi Wang; Hui Zhou; Cheng Zhen; Jinjian Yang; Fengyan Tian; Guan Wu
Journal:  World J Urol       Date:  2019-06-17       Impact factor: 4.226

10.  HoLEP: the gold standard for the surgical management of BPH in the 21(st) Century.

Authors:  John Michalak; David Tzou; Joel Funk
Journal:  Am J Clin Exp Urol       Date:  2015-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.